TrialEuropean journal of nuclear medicine and molecular imaging2017

Total lesion glycolysis (TLG) as an imaging biomarker in metastatic colorectal cancer patients treated with regorafenib.

Yoojoo Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.